Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.055 USD | -3.22% | -13.49% | -61.93% |
05-10 | Annovis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-09 | Annovis Bio, Inc. Announces Unblinding of the Buntanetap Phase III Data in Parkinson?s Disease | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.93% | 81.44M | |
+10.40% | 118B | |
+10.44% | 106B | |
-10.00% | 23.4B | |
-1.78% | 22.1B | |
-10.26% | 18.34B | |
-41.92% | 16.59B | |
-14.72% | 15.97B | |
+6.06% | 14.03B | |
+16.76% | 11.67B |
- Stock Market
- Equities
- ANVS Stock
- News Annovis Bio, Inc.
- Annovis Bio Appoints Henry Hagopian III CFO